🔗 Permalink

Inventor profile of:

Christian Gege

City:

Ehingen

Country:

Germany

Published Applications:

48

Last publication date:

2026-05-21

Top Assignees for applications by Christian Gege

The entities that hold a legal rights for patent applications filed by inventor Gege Christian:

PHENEX PHARMACEUTICALS AG 5 Ludwigshafen, Germany
Janssen Pharmaceutica NV 4 Beerse, Belgium
Gilead Sciences, Inc. 4 Foster City, CA United States
Janssen Pharmaceutica NV 3 New Brunswick, NJ United States
Phenex-FXR GmbH 3 Heidelberg, Germany
Innovative Molecules GMBH 2 Munich, Germany
INNOVATIVE MOLECULES GMBH 2 München, Germany
OrsoBio, Inc. 2 Palo Alto, CA United States
SCHERING AG 2 Berlin, Germany
Bayer Schering Pharma Aktiengesellschaft 1 Berlin, Germany
Alantos Pharmaceuticals Holding, Inc. 1 Thousand Oaks, CA United States
Innovative Molecules GmbG 1 Munich, Germany
Innovative Molecules GmbH 1 Bad Salzuflen, Germany
ORSOBIO, INC. 1 Menlo Park, CA United States
Sterix Limited 1 Berkshire, United Kingdom
Alantos Pharmaceutical Holdings, Inc. 1 Thousand Oaks, CA United States
Janssen Pharmaceutiuca NV 1 Beerse, Belgium
Immunic AG 1 Gräfelfing, Germany

Recent patent applications by Gege Christian

Christian Gege from Ehingen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-21

US20260137669A1

Human necessities

NOVEL ENANTIOMERS OF A SERIES OF ANTIVIRAL COMPOUNDS

#2 | 2026-05-14

US20260130879A1

Human necessities

VIDOFLUDIMUS AND RELATED STRUCTURES ACTING AS NURR1 AGONISTS

#3 | 2025-07-31

US20250243190A1

Chemistry; metallurgy

NEW DEUTERATED RORGAMMA/RORGAMMAT INVERSE AGONISTS

#4 | 2025-04-10

US20250115565A1

Chemistry; metallurgy

SOLID CRYSTALLINE FORMS OF HELICASE-PRIMASE INHIBITORS AND PROCESS OF PREPARATION THEREOF

#5 | 2025-02-27

US20250066290A1

Chemistry; metallurgy

DHODH INHIBITORS CONTAINING A CARBOXYLIC ACID BIOISOSTERE

#6 | 2025-01-30

US20250032527A1

Human necessities

MEDICAL USE OF N4-HYDROXY CITICOLINE COMPOUNDS

#7 | 2024-12-12

US20240408068A1

Human necessities

Helicase Primase Inhibitors For Treating Cancer In A Combination Therapy With Oncolytic Viruses

#8 | 2024-11-07

US20240368145A1

Chemistry; metallurgy

METHODS FOR TREATING CANCER

#9 | 2024-10-10

US20240335405A1

Human necessities

VIDOFLUDIMUS AND RELATED STRUCTURES ACTING AS NURR1 AGONISTS

#10 | 2024-09-26

US20240317726A1

Chemistry; metallurgy

LXR modulators with bicyclic core moiety

#11 | 2024-09-26

US20240316021A1

Human necessities

NOVEL ENANTIOMERS OF A SERIES OF ANTIVIRAL COMPOUNDS

#12 | 2024-06-20

US20240199535A1

Chemistry; metallurgy

DEUTERATED DHODH INHIBITORS

#13 | 2023-12-07

US20230391738A1

Chemistry; metallurgy

DEUTERATED AMINOTHIAZOLE COMPOUNDS AS ANTIVIRAL COMPOUNDS

#14 | 2023-11-09

US20230357214A1

Chemistry; metallurgy

LXR modulators with bicyclic core moiety

#15 | 2022-06-30

US20220204460A1

Chemistry; metallurgy

FXR (NR1H4) modulating compounds

#16 | 2022-05-19

US20220152008A1

Human necessities

Enantiomers of substituted thiazoles as antiviral compounds

#17 | 2021-12-30

US20210401810A1

Human necessities

Helicase Primase Inhibitors For Treating Cancer In A Combination Therapy With Oncolytic Viruses

#18 | 2021-10-21

US20210323995A1

Chemistry; metallurgy

ISOLITHOCHOLIC ACID OR ISOALLOLITHOCHOLIC ACID AND DEUTERATED DERIVATIVES THEREOF FOR PREVENTING AND TREATING CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASES

#19 | 2021-05-20

US20210147398A1

Chemistry; metallurgy

LXR modulators with bicyclic core moiety

#20 | 2020-11-26

US20200369632A1

Chemistry; metallurgy

FXR (NR1H4) modulating compounds

#21 | 2020-09-17

US20200289486A1

Human necessities

Enantiomers of substituted thiazoles as antiviral compounds

#22 | 2020-05-14

US20200148652A1

Chemistry; metallurgy

Aminothiazole Derivatives Useful As Antiviral Agents

#23 | 2020-04-30

US20200131144A1

Chemistry; metallurgy

AMINE OR (THIO)AMIDE CONTAINING LXR MODULATORS

#24 | 2020-04-16

US20200115357A1

Chemistry; metallurgy

LIVER X RECEPTORS (LXR) MODULATORS

#25 | 2019-04-18

US20190112285A1

Chemistry; metallurgy

Aminothiazole derivatives useful as antiviral agents

#26 | 2018-03-08

US20180064690A1

Human necessities

Thiazoles as modulators of RORγt

#27 | 2017-11-16

US20170327492A1

Chemistry; metallurgy

Trifluoromethyl alcohols as modulators of RORγt

#28 | 2017-10-19

US20170298068A1

Chemistry; metallurgy

FXR (NR1H4) modulating compounds

#29 | 2016-06-23

US20160176861A1

Chemistry; metallurgy

Hydroxy containing FXR (NR1H4) modulating compounds

#30 | 2016-05-05

US20160122336A1

Chemistry; metallurgy

Trifluoromethyl alcohols as modulators of RORγt

#31 | 2016-05-05

US20160122335A1

Chemistry; metallurgy

Amide substituted thiazoles as modulators of RORyt

#32 | 2016-05-05

US20160120850A1

Human necessities

Thiazoles as modulators of RORγt

#33 | 2015-12-03

US20150344423A1

Chemistry; metallurgy

Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor RORγ

#34 | 2015-06-25

US20150175562A1

Chemistry; metallurgy

Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ]

#35 | 2014-11-27

US20140349987A1

Chemistry; metallurgy

Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases

#36 | 2014-05-22

US20140142082A1

Chemistry; metallurgy

Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases

#37 | 2008-12-11

US20080306164A1

Chemistry; metallurgy

2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

#38 | 2008-10-23

US20080261968A1

Chemistry; metallurgy

Heterobicyclic metalloprotease inhibitors

#39 | 2008-09-11

US20080221092A1

Chemistry; metallurgy

Heterobicyclic metalloprotease inhibitors

#40 | 2008-09-11

US20080221083A1

Chemistry; metallurgy

Heterobicyclic metalloprotease inhibitors

#41 | 2008-08-28

US20080207607A1

Chemistry; metallurgy

Heterotricyclic metalloprotease inhibitors

#42 | 2008-07-24

US20080176870A1

Chemistry; metallurgy

Heterobicyclic metalloprotease inhibitors

#43 | 2008-01-24

US20080021024A1

Chemistry; metallurgy

Metalloprotease inhibitors

#44 | 2007-07-05

US20070155739A1

Chemistry; metallurgy

Substituted bis-amide metalloprotease inhibitors

#45 | 2006-09-21

US20060211670A1

Chemistry; metallurgy

Antitumoral18a-homoestra-1,3,5(10)-trien-3yl 2-substituted sulfamates

#46 | 2006-07-13

US20060154985A1

Chemistry; metallurgy

Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates

#47 | 2006-03-09

US20060052461A1

Chemistry; metallurgy

2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

#48 | 2006-01-12

US20060009434A1

Chemistry; metallurgy

2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

InventorID:

771598 ⎘